跳至主要内容
临床试验/NCT06212921
NCT06212921招募中不适用

Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)

University of Tartu4 个研究点 分布在 2 个国家目标入组 250 人开始时间: 2024年10月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
4
主要终点
Rate of correctly predicted cases of acute mesenteric ischaemia

研究概览

简要总结

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Initial decision in favour of further diagnostics of mesenteric ischaemia

排除标准

  • Age <18 years
  • Consent declined by patient or next of kin (delayed consent)
  • Chronic mesenteric ischaemia without an acute event
  • Immediate decision for withdrawal of further diagnostics and active treatment
  • Referral from another hospital with already established diagnosis of AMI
  • AMI diagnosed at surgery without previously having been considered

结局指标

主要结局

Rate of correctly predicted cases of acute mesenteric ischaemia

时间窗: 10 months

Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Annika Reintam Blaser

Associate Professor

University of Tartu

研究点 (4)

Loading locations...

相似试验